Markets:

Overview

News

Currencies

International

Treasuries

Precision BioSciences, Inc. - Common Stock (NQ:DTIL)

4.070 -0.030 (-0.73%)

Streaming Delayed Price Updated: 3:39 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Precision BioSciences, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Precision BioSciences Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

November 28, 2023

From Precision BioSciences, Inc.

Via Business Wire

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

November 14, 2023

Via ACCESSWIRE

Precision BioSciences Presents Late-Breaking Data Highlighting Preclinical Efficacy and Safety of PBGENE-HBV for Chronic Hepatitis B at AASLD’s The Liver Meeting 2023

November 13, 2023

From Precision BioSciences, Inc.

Via Business Wire

Earnings Outlook For Precision BioSciences ↗

November 06, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About Precision BioSciences ↗

September 19, 2023

Via Benzinga

Precision BioSciences to Present at Upcoming Sidoti Conference

November 10, 2023

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Announces Late-Breaking Poster Presentation at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting

November 09, 2023

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Reports Third Quarter 2023 Financial Results and Provides Business Update

November 07, 2023

From Precision BioSciences, Inc.

Via Business Wire

The Latest Analyst Ratings for Precision BioSciences ↗

August 17, 2023

Via Benzinga

A Preview Of Precision BioSciences's Earnings ↗

August 03, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 01, 2023

Via Benzinga

Precision BioSciences to Report Third Quarter Results on November 7, 2023

November 01, 2023

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Presents Preclinical Data Highlighting Capabilities of ARCUS for Gene Insertion and Excision at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress

October 26, 2023

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences to Present at Upcoming H.C. Wainwright 4th Annual Hepatitis B Virus Conference

October 23, 2023

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress

October 12, 2023

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Receives U.S. Patent Allowance Covering PBGENE-PMM for m.3243-Associated Mitochondrial Diseases

September 27, 2023

From Precision BioSciences, Inc.

Via Business Wire

Why Femasys Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket ↗

September 26, 2023

Gainers Femasys Inc. (NASDAQ: FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment.

Via Benzinga

Precision BioSciences Hosts Virtual R&D Day Highlighting its Proprietary ARCUS Technology and Recent In Vivo Gene Editing Program Developments

September 12, 2023

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences to Attend and Present at Upcoming September Investor Conferences

September 06, 2023

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences to Host In Vivo Gene Editing R&D Day on September 12, 2023

August 31, 2023

From Precision BioSciences, Inc.

Via Business Wire

What Is Precision BioSciences CAR T Pipeline Value? Analyst Lowers Price Target To Justify Valuation ↗

August 17, 2023

Wednesday, Precision BioSciences Inc (NASDAQ: DTIL) announced the completion of a strategic transaction with Imugene Limited for global rights to Azercabtagene Zapreleucel (azer-cel), Precision's lead...

Via Benzinga

Why Is Precision BioSciences Stock Soaring Today? ↗

August 16, 2023

Precision BioSciences Inc (NASDAQ: DTIL) announced the completion of a strategic transaction with Imugene Limited for global rights to Azercabtagene Zapreleucel (azer-cel), Precision's lead allogeneic...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 16, 2023

Via Benzinga

Why DLocal Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket ↗

August 16, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 16, 2023

Investors will want to get ready for another busy day of trading as we cover the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

Precision BioSciences Completes Strategic Transaction with Imugene for Azer-Cel in Cancer

August 15, 2023

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Reports Second Quarter 2023 Financial Results and Provides Business Update

August 04, 2023

From Precision BioSciences, Inc.

Via Business Wire

Earnings Scheduled For August 4, 2023 ↗

August 04, 2023

Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first quarter. • Anglogold Ashanti (NYSE:AU) is likely to report earnings for its first quarter.

Via Benzinga

Precision BioSciences to Report Second Quarter Results on August 4, 2023

August 01, 2023

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Provides Updates on Azer-Cel FDA Meeting, Potential Partnerships and Timing of In Vivo R&D Day

July 27, 2023

From Precision BioSciences, Inc.

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.